REVIUM Rx. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
REVIUM Rx. (RVRC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $437.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- REVIUM Rx. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $437.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2024-12-31 | $437.00K 10-K · filed 2026-03-31 |